BSE filing, NSE: EMKAY. Summary written from the filing by ALFA Finder's alert engine.
Emkay Global Financial Services Ltd: key numbers
- Share price
- ₹286.75
- Market cap
- ₹801.1 Cr
- Revenue (annual)
- ₹377.0 Cr
- Net profit (annual)
- ₹15.20 Cr
- P/E (TTM)
- 41.0×Sector 19.7×
- Promoter holding
- 72.89%+0.06% QoQ
- FII holding
- 0.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Emkay Global Financial Services Ltd
All →Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Emkay Global Financial Services Investor Presentation: Key Takeaways
Record Q2 FY27: consolidated revenue ₹1,567 Mn (+103% YoY) and PAT ₹310 Mn (+6,100% YoY). Wealth AUM ₹199,782 Mn (+9%); PMS+AIF AUM ₹25,624 Mn (+64%). Focus on distribution expansion and technology.
Emkay Global Financial Services Q2 FY27 Results: Net Profit ₹31 Cr, Up 6100.0% YoY
Emkay Global Financial Services Ltd reported revenue from operations of ₹151.3 Cr (+109.8% YoY) and net profit of ₹31 Cr (+6100.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹31 Cr · +6100.0% YoY
Emkay Global Financial Services Board Meeting Date
Emkay Global Financial Services has scheduled a board meeting for October 28, 2026, to consider its unaudited half-yearly financial results.
Emkay Global Financial Services Other Announcement
Emkay Global Financial Services Ltd has filed its quarterly shareholding pattern as per Regulation 31(1)(b). This is a routine regulatory compliance disclosure.
Emkay Global Financial Services Convertible Warrants
Emkay Global received BSE listing approval for 1,00,000 shares converted from warrants to promoter Kacholia. Value: Rs. 2.40 Crore at Rs. 239.50 per share.
- Value
- ₹2.40 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date